4XL Study - Obesity Surgery in Adolescence (4XL)

April 21, 2026 updated by: Jøran Hjelmesæth, Sykehuset i Vestfold HF

4XL-Study - Obesity Surgery in Adolescence

The purpose of this study on adolescents between 13 and 18 years of age with morbid obesity is to determine whether surgical treatment gives more health benefits than standard conservative treatment, and if laparoscopic gastric bypass is a method with high safety and a low complication rate.

Study Overview

Detailed Description

The study has two intervention arms:

Experimental: Group A Surgery; laparoscopic gastric bypass

Active comparator: Group B Patients from Child Obesity Registry of Vestfold who get standard conservative treatment in a multidisiplinary team at Morbid Obesity Center.

All patients are referred to Morbid Obesity Center from other hospitals or general practionairs in Norway. The procedure will take place at the Vestfold Hospital Trust The participants are included for 2 years follow-up with visits to a multidisciplinary team every 3rd month at the Morbid Obesity Center. Total follow-up time is ten years.

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tønsberg, Norway, 3103
        • Morbid Obesity Center, The Hospital of Vestfold, South-Eastern Norway Regional Health Authority

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Between 13 and 18 years of age at inclusion
  • Tanner stage 4-5
  • BMI > 40 kg/m2 or BMI > 35 with at least one comorbidity (type 2-diabetes, obstructive sleep apnea, serious hypertension or cerebral pseudotumor)
  • At least one year multidisciplinary treatment completed

Exclusion Criteria:

  • Tanner stage < 4
  • Substantial risk for lack of compliance
  • Obesity syndrome (e.g., Prader Willi syndrome)
  • Obesity related to brain damage
  • Serious general disease
  • Monogenic obesity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A
Laparoscopic Gastric Bypass
Patients are referred to Morbid Obesity Center from Vestfold Hospital Trust and other hospitals in Norway. The procedure will take place at Morbid Obesity Center, Vestfold Hospital Trust.
Active Comparator: Group B
Standard conservative treatment. Patients from Child Obesity Registry of Vestfold.
Participants from Child Obesity Registry who undergoes conservative treatment at Morbid Obesity Center, Vestfold Hospital Trust.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BMI and weight loss
Time Frame: Baseline, Year 1, 2, 5, 10
Surgical or standard conservative treatment
Baseline, Year 1, 2, 5, 10

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life (KINDL)
Time Frame: 10 years
Web-based questionnaire baseline and after 1, 2, 5 and 10 years.
10 years
Eating Disorders (Child Eating Behavior Questionnaire)
Time Frame: 10 years
Web-based questionnaire baseline and after 1, 2, 5 and 10 years.
10 years
Mental Health (Development and Well-Being Assessment, DAWBA)
Time Frame: 10 years
Web-based questionnaire baseline and after 1, 2, 5 and 10 years.
10 years
Self-Esteem (Rosenberg Self-Esteem scale)
Time Frame: 10 years
Web-based questionnaire baseline and after 1, 2, 5 and 10 years.
10 years
Surgical and Medical Complications
Time Frame: 10 years
Web-based questionnaire baseline and after 1, 2, 5 and 10 years.
10 years
Blood sample results
Time Frame: 10 years
Blood tests are biobanked at baseline and after 1, 2, 5 and 10 years.
10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Samira Lekhal, PhD,MD, Vestfold Hospital Trust/The Hospital of Vestfold
  • Study Chair: Jøran Hjelmesæth, MD, PhD, Vestfold Hospital Trust/The Hospital of Vestfold

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2009

Primary Completion (Estimated)

August 1, 2033

Study Completion (Estimated)

December 1, 2035

Study Registration Dates

First Submitted

June 17, 2009

First Submitted That Met QC Criteria

June 17, 2009

First Posted (Estimated)

June 18, 2009

Study Record Updates

Last Update Posted (Actual)

April 24, 2026

Last Update Submitted That Met QC Criteria

April 21, 2026

Last Verified

March 1, 2026

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity, Morbid

Clinical Trials on Laparoscopic gastric bypass

Subscribe